Clinical Trial Update: CHOICE: CHanges to Treatment and Outcomes in Patients With Type 2 Diabetes Initiating InjeCtablE Therapy

View source ↗

Summary

This clinical trial update reports a completed study of patients with Type 2 Diabetes Mellitus initiating InjeCtablE Therapy; results were posted on 2014-07-09.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• InjeCtablE Therapy

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes Mellitus | Status: COMPLETED | Results posted: 2014-07-09